Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
2.080
+0.010 (0.48%)
At close: Dec 26, 2025, 4:00 PM EST
2.080
0.00 (-0.01%)
After-hours: Dec 26, 2025, 7:51 PM EST

Milestone Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
21115672169276200
Upgrade
Market Cap Growth
68.33%117.39%-57.49%-38.80%38.33%-49.05%
Upgrade
Enterprise Value
186134479515198
Upgrade
Last Close Price
2.082.361.673.966.556.70
Upgrade
PS Ratio
--71.9133.8318.43-
Upgrade
PB Ratio
10.3111.894.292.552.461.40
Upgrade
P/TBV Ratio
10.3111.894.292.552.461.40
Upgrade
EV/Sales Ratio
--47.1918.9010.05-
Upgrade
Debt / Equity Ratio
2.794.173.090.040.010.01
Upgrade
Asset Turnover
--0.010.050.11-
Upgrade
Quick Ratio
7.998.799.3410.7216.9223.26
Upgrade
Current Ratio
8.249.1010.1111.7017.5524.14
Upgrade
Return on Equity (ROE)
-260.65%-277.55%-143.61%-65.26%-33.52%-38.73%
Upgrade
Return on Assets (ROA)
-41.97%-34.92%-51.01%-38.36%-19.95%-23.18%
Upgrade
Return on Capital (ROIC)
-45.93%-38.56%-55.59%-40.93%-20.92%-24.43%
Upgrade
Return on Capital Employed (ROCE)
-74.10%-62.50%-89.80%-87.30%-38.10%-35.30%
Upgrade
Earnings Yield
-27.46%-26.56%-83.00%-34.52%-15.50%-25.01%
Upgrade
FCF Yield
-20.42%-18.48%-64.72%-31.18%-12.02%-25.39%
Upgrade
Buyback Yield / Dilution
-31.08%-44.82%-1.19%-1.47%-42.56%-85.91%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q